Autonomous Effects of Catheter Radiofrequency Pulmonary Vein Isolation Ablation Using a High-Power and Short-Duration Technique

Keywords: heart rate variability, parasympathetic tone, vagus nerve, tachycardia, pacemaker, navigation system

Abstract

Introduction. Catheter-based pulmonary vein ablation (PVA) is the gold standard for the treatment of symptomatic, drug-refractory atrial fibrillation (AF). The effect of catheter ablation on the autonomic nervous system, particularly the parasympathetic system–referred to as the “cardioneuroeffect” – represents an important side effect that may contribute to more stable outcomes of the procedure.

Aim. To investigate the intraoperative autonomic effects of high-power, short-duration pulmonary vein isolation.

Materials and Methods. For this retrospective study, 49 patients with paroxysmal and persistent forms of AF were selected, in whom long-term outcomes regarding arrhythmia recurrence could be tracked. All patients underwent catheter-based radiofrequency ablation at the State Institution “National Institute of Cardiovascular Surgery named after M. M. Amosov of the National Academy of Medical Sciences of Ukraine” between May 2022 and December 2024.

Results. Over a mean observation period of 19.87 ± 7.56 months (range 8-34), recurrences occurred in 19 out of 49 patients (38 %). In patients without recurrence, there was a pronounced decrease in the R-R interval during the intervention (889.33 ± 157.48 vs. 762.92 ± 133.81 ms, p=0.003) and a significant increase in heart rate (69 ± 11.96 vs. 80.67 ± 15.53 bpm, p=0.003). In patients with recurrence, changes in the R-R interval and heart rate were not statistically significant (p=0.09 and p=0.117), indicating smaller autonomic modulation. At the end of the procedure, the R-R interval and heart rate were significantly higher and lower, respectively, in the recurrence group (874.25 ± 137.06 ms vs. 762.92 ± 133.81 ms, p=0.029; 69.75 ± 11.85 vs. 80.67 ± 15.53 bpm, p=0.022). Patients with recurrence had a higher mean degree of left atrial fibrosis according to voltage mapping (1.64 ± 1.21 vs. 0.84 ± 0.72), but this difference did not reach statistical significance (p=0.11). Absence of reconnection during the intervention was observed in 62.5 % of patients without recurrence, compared to only 30.8 % in the recurrence group. Reconnection in two veins occurred exclusively in the recurrence group (54 % of cases), which was not observed in any patient without recurrence. This difference was statistically significant (p=0.003).

Conclusions. During catheter radiofrequency isolation of the pulmonary veins in patients with paroxysmal and persistent AF, a more pronounced effect of cardioneuromodulation was associated with a reduction in arrhythmia recurrences during the postoperative period.

References

  1. Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJG, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024 Sep 21;45(36):3314-3414. https://doi.org/10.1093/eurheartj/ehae176
  2. Tzeis S, Gerstenfeld EP, Kalman J, Saad EB, Sepehri Shamloo A, Andrade JG, et al. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. EP Europace. 2024 Apr;26(4):euae043. https://doi.org/10.1093/europace/euae043
  3. Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 2;149(1):e1-e156. https://doi.org/10.1161/CIR.0000000000001193 .
  4. von Olshausen G, Saluveer O, Schwieler J, Drca N, Bastani H, Tapanainen J, Bourke T, Paul-Nordin A, Kennebäck G, Insulander P, Jensen-Urstad M, Braunschweig F. Sinus heart rate post pulmonary vein ablation and long-term risk of recurrences. Clin Res Cardiol. 2021 Jun;110(6):851-860. https://doi.org/10.1007/s00392-020-01765-z .
  5. Vassallo F, Cunha C, Corsino L, Serpa E, Simões A Jr, Hespanhol D, Lovatto CV, Gasparini D, Barbosa LF, Schmidt A. High Power Short Duration Atrial Fibrillation Ablation: Long-Term Predictors of Success and Recurrence - A Multivariate Analysis. Arq Bras Cardiol. 2024 Nov;121(12):e20230837. Portuguese, English. https://doi.org/10.36660/abc.20230837 .
  6. Vassallo F, Corcino L, Cunha C, Serpa E, Lovatto C, Simoes A Jr, Carloni H, Hespanhol D, Gasparini D, Barbosa LF, Schmidt A. Incidental parasympathetic cardiac denervation during atrial fibrillation ablation using high power short duration: a marker of long-term success. J Interv Card Electrophysiol. 2025 Mar;68(2):371-377. https://doi.org/10.1007/s10840-023-01653-2 .
  7. Vassallo F, Meigre LL, Cunha C, Serpa E, Simoes A Jr, Lovatto C, Gasparini D, Corcino L, Schmidt A. Comparison of outcomes with low-power long duration versus high-power short duration of ablation: the role of the acute change in sinus rhythm after the ablation as a predictor of long-term success. Heart Vessels. 2022 Oct;37(10):1749-1756. https://doi.org/10.1007/s00380-022-02066-3.
  8. Yang N, Zou Y, Wen B, Wang Y, Mei J, Jiang Z. Development of neuromodulation for atrial fibrillation: a narrative review. J Thorac Dis. 2024 May 31;16(5):3472-3483. https://doi.org/10.21037/jtd-23-1981.
  9. Yu HT, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Pak HN. Prognosis of high sinus heart rate after catheter ablation for atrial fibrillation. Europace. 2017 Jul 1;19(7):1132-1139. https://doi.org/10.1093/europace/euw142.
  10. Goff ZD, Laczay B, Yenokyan G, Sivasambu B, Sinha SK, Marine JE, Ashikaga H, Berger RD, Akhtar T, Spragg DD, Calkins H. Heart rate increase after pulmonary vein isolation predicts freedom from atrial fibrillation at 1 year. J Cardiovasc Electrophysiol. 2019 Dec;30(12):2818-2822. https://doi.org/10.1111/jce.14257.
  11. Wang K, Chang D, Chu Z, Yang Y, Gao L, Zhang S, Xia Y, Dong Y, Yin X, Cong P, Jia J. Denervation as a common mechanism underlying different pulmonary vein isolation strategies for paroxysmal atrial fibrillation: evidenced by heart rate variability after ablation. ScientificWorldJournal. 2013 Aug 24;2013:569564. https://doi.org/10.1155/2013/569564 .
  12. Zhang E, Liang S, Sun T, Xu J, Lu F, Wu D, Zhang J, He L, Zhang F, Fan S, Ma W. Prognostic value of heart rate variability in atrial fibrillation recurrence following catheter ablation: A systematic review and meta-analysis. Front Cardiovasc Med. 2023 Feb 2;9:1048398. https://doi.org/10.3389/fcvm.2022.1048398 .
  13. Drexler M, Blum T, Heinroth KM, Hartkopf T, Plehn A, Schirdewahn P, Sedding DG. Heart rate variability as a predictor of successful catheter-guided pulmonary vein isolation for atrial fibrillation. Herz. 2024 Mar;49(2):147-154. https://doi.org/10.1007/s00059-023-05201-6 .
  14. Musikantow DR, Neuzil P, Petru J, Koruth JS, Kralovec S, Miller MA, Funasako M, Chovanec M, Turagam MK, Whang W, Sediva L, Dukkipati SR, Reddy VY. Pulsed Field Ablation to Treat Atrial Fibrillation: Autonomic Nervous System Effects. JACC Clin Electrophysiol. 2023 Apr;9(4):481-493. https://doi.org/10.1016/j.jacep.2022.10.028 .
  15. Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, Telishevska M, Otgonbayar U, Koch-Büttner K, Lennerz C, Bartkowiak M, Kornmayer M, Rousseva E, Brkic A, Grebmer C, Kolb C, Hessling G, Deisenhofer I. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace. 2020 Mar 1;22(3):388-393. https://doi.org/10.1093/europace/euz342 .
  16. O'Brien B, Reilly J, Coffey K, González-Suárez A, Buchta P, Buszman PP, Lukasik K, Tri J, van Zyl M, Asirvatham S. Epicardial Pulsed Field Ablation of Ganglionated Plexi: Computational and Pre-Clinical Evaluation of a Bipolar Sub-Xiphoid Catheter for the Treatment of Atrial Fibrillation. Bioengineering (Basel). 2023 Dec 24;11(1):18. https://doi.org/10.3390/bioengineering11010018.
Published
2025-09-25
How to Cite
1.
Perepeka EO. Autonomous Effects of Catheter Radiofrequency Pulmonary Vein Isolation Ablation Using a High-Power and Short-Duration Technique. ujcvs [Internet]. 2025Sep.25 [cited 2025Oct.9];33(3):99-105. Available from: https://www.cvs.org.ua/index.php/ujcvs/article/view/762

Most read articles by the same author(s)